AUTOMATED VERSUS MANUAL REANALYSIS IN RARE DISEASE GENOMICS
Preprint
Abstract
Purpose: Periodic reanalysis of genome sequencing data can yield additional diagnoses as knowledge evolves, yet manual reanalysis is labour-intensive. We compared automated and manual reanalysis approaches in rare disease genomics. Methods: We reanalyzed 377 rare disease cases: 158 with pathogenic or likely pathogenic (P/LP) findings, 49 with variants of uncertain significance (VUS) findings, and 170 had no findings. Manual reanalysis used standard diagnostic workflow for all cases without prior P/LP diagnoses (219 cases). An automated pipeline using Talos was benchmarked on the 158 P/LP cases before application to the 219-case reanalysis cohort. The mean reanalysis interval was 660 days. Results: Manual reanalysis identified three additional P/LP cases and two newly classified as VUS, increasing P/LP cases from 158 (41.9%) to 161 (42.7%). Talos recovered all three P/LP findings but only identified one of the two new VUS findings. Benchmarking showed 80.0% singleton concordance and 75.2% (82.8% proband-only) trio concordance, with an output of approximately three variants per case. Conclusion: Reanalysis at 1.8 years yields modest but clinically meaningful gain. Automated reanalysis closely approximates manual performance while reducing hands-on effort, supporting scalable reanalysis in routine genomic care.Keywords
This publication has 31 references indexed in Scilit:
- Pathogenic XPO1 variants cause a dominant neurodevelopmental disorderGenetics in Medicine, 2025
- Evaluation of an automated genome interpretation model for rare disease routinely used in a clinical genetic laboratoryGenetics in Medicine, 2023
- Deleterious, protein-altering variants in the transcriptional coregulator ZMYM3 in 27 individuals with a neurodevelopmental delay phenotypeThe American Journal of Human Genetics, 2022
- Recommendations for next generation sequencing data reanalysis of unsolved cases with suspected Mendelian disorders: A systematic review and meta-analysisGenetics in Medicine, 2022
- Automated reanalysis application to assist in detecting novel gene–disease associations after genome sequencingGenetics in Medicine, 2022
- Evaluating systematic reanalysis of clinical genomic data in rare disease from single center experience and literature reviewMolecular Genetics & Genomic Medicine, 2020
- The Responsibility to Recontact Research Participants after Reinterpretation of Genetic and Genomic Research ResultsThe American Journal of Human Genetics, 2019
- VariantValidator: Accurate validation, mapping, and formatting of sequence variation descriptionsHuman Mutation, 2017
- GeneMatcher: A Matching Tool for Connecting Investigators with an Interest in the Same GeneHuman Mutation, 2015
- DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl ResourcesThe American Journal of Human Genetics, 2009